Skip to main content
Heliyon logoLink to Heliyon
. 2024 Jun 5;10(12):e32175. doi: 10.1016/j.heliyon.2024.e32175

Effect of Nurse's detection of neurological deterioration on the prognosis of patients with acute cerebral infarction

Jung-Hee Han a, Claire Han b, Sunmae Park a, Young-Joo Kim a, Bum Joon Kim c,
PMCID: PMC11341237  PMID: 39183862

Abstract

Introduction

There is little evidence about the factors related to the detection of neurological deterioration by nurses. We examined the related factors and therapeutic outcomes of nurses' detections of patient's neurological deterioration.

Methods

This was a descriptive retrospective study. We included 549 adult stroke patients who were admitted to the acute stroke unit of a tertiary hospital between May 2018 and December 2019 and had changes in neurological symptoms that were detected by stroke nurses. We measured the following outcomes: stroke lesion progression, early neurological deterioration (increase in the total national institutes of health stroke scale score of 2 points or more, increase in the limb weakness score of 1 point or more, or decrease in the alertness score of 1 point or more), and additional clinical management (increasing intravenous fluids, diagnostic imaging, or neuro-intervention). Data was analyzed by logistic regression.

Results

A total of 651 new or aggravating symptoms were detected by nurses. The most detected symptom was motor aggravations (49.2 %). Symptoms were commonly detected during the day shift (51.0 %) and by scheduled neurochecks (71.3 %). Of 132 patients who underwent diagnostic imaging by nurses’ detection, 63.6 % cases had stroke lesion progression. Nursing experience over 4 years was positively associated with finding stroke lesion progression (OR: 2.49, 95 % CI = 1.09–5.67). Early neurological deterioration was found in 70.7 %, and it was significantly higher during scheduled neurochecks (OR:2.65, 95 % CI = 1.04–6.72) and in the group of large artery atherosclerosis (OR: 2.19, 95 % CI = 1.06–4.49) Additional clinical management was provided to 49.9 % of detection, and scheduled neurocheks (OR: 4.76, 95 % CI = 2.18–10.39) and changes of alertness (OR: 2.89, 96 % CI = 1.51–5.26) were the significant factors.

Conclusion

Stroke nurses were able to detect a large number of stroke lesion progression and early neurological deterioration as well as to provide additional clinical management. Systematic guidelines for qualification of stroke nurses may be beneficial.

Keywords: Stroke, Cerebral infarction, Nurse, Neurological deterioration, Detection, Prognosis

Highlights

  • •Stroke nurses were able to detect neurological deterioration related to stroke lesion progression (63.6 %) and early neurological deterioration (70.7 %) and needing additional clinical management (49.9 %) with a high probability.

  • •Scheduled neurochecks was not only tended to have a significant impact on detecting early neurological deterioration, but also those which requires additional clinical managements.

  • •Stroke lesion progression was detected highly from patients with NIHSS score 7–15, large artery atherosclerosis stroke subtype and by experienced nurses.

  • •In detecting early neurological deterioration, scheduled neurochecks and the stroke etiology of large artery atherosclerosis were the significant factors.

  • •In terms of the deterioration requiring additional clinical management, heart disease, NIHSS score of 0–6, changes of alertness, and detection by scheduled neurochecks were significantly associated factors.

1. Introduction

Stroke is one of the top five causes of disability worldwide [1], and is responsible for severe functional and quality-of-life impairment, which leads to disabilities in daily life [2]. Impairment after an acute stroke occurs in multiple conditions, including speech, language, dysphagia, incontinence, visual impairment, and physical impairment [1]. Notably, early detection of neurological symptom changes and intervention is critical to prevent further decline of physical and emotional conditions during the acute phase of stroke [1].

Assessing neurological symptoms in patients with acute cerebral infarction is one of the most basic aspects of nursing care. Early neurological deterioration (END) refers to the clinical worsening or recurrence in the acute stage of ischemic stroke [[3], [4], [5], [6]], and is a common complication worldwide. The consequences of END are critical as they result in a worse quality of life and functional outcome in stroke patients [4,7,8]. The rate of END ranges from 15 % to 37 % across different populations [5,9]. Symptomatic changes in patients with acute cerebral infarction can be detected in their early stages by nurses [10]. Identifying clinically significant factors among the findings of nurses can make the patient more aware of the cause of deterioration, which can lead to a better prognosis.

Among different types of healthcare workers, nurses are often those who can detect the worsening of symptoms at the earliest stages [[11], [12], [13]]. Early detection of symptom changes leads to a better quality of treatment for stroke patients [10,12,13]. Accordingly, in the acute stroke unit (ASU), nurses are trained in various ways (e.g., videos and scenarios) to assess patients using the National Institutes of Health Stroke Scale (NIHSS) score [11,14,15], which significantly affects the predictive rate of deterioration by nurses [10,11,13,14]. Therefore, nurses who see stroke patients on a daily basis have an important role in accurately assessing the patient's condition and quickly detecting changes in symptoms. Although it is essential for nurses to check the status of stroke patients using the NIHSS score [10,11,13], there are only a few studies examining the effects of nurses' detection of END on therapeutic outcomes. Furthermore, understanding the factors related to the nurses' detection of END may be helpful in improving the rate of early detection and optimal management.

The purpose of this study is to explore the clinical effects of nurses’ detection on the changes in neurological symptoms among acute stroke patients with the objectives below.

  • 1)

    To determine the symptoms detected by nurses and their related factors

  • 2)

    To assess the factors related to the presence of stroke lesion progression

  • 3)

    To determine the factors related to the presence of END

  • 4)

    To assess the factors related to the presence of additional clinical management

2. Methods

2.1. Study design, patients, and data collection

This was a descriptive study based on retrospective data analysis using electronic medical records. We included adult (age ≥18 years) Stroke patients who were admitted to the ASU at Asan Medical Center (Seoul, South Korea) between May 1, 2018 and December 31, 2019 and whose neurological symptoms were detected by a nurse. We included patients with both clear and unclear symptom onset. We excluded patients whose final diagnosis at discharge was not stroke. The indications of the ASU admission from the center protocol were as belows.

  • Patients with acute stroke whose symptoms manifest within 72 h.

  • Patients whose NIHSS score worsens by 1 point or more, even if more than 72 h have passed since symptom onset.

  • Patients with acute stroke who have experienced a recent recurrence or worsening within the last week after the acute phase, and whose condition is unstable, requiring intensive monitoring.

  • Patients who have received intravenous thrombolysis for acute stroke treatment.

All data were collected through the electronic medical record including the nursing record, NIHSS score record, laboratory sheet, progress record, doctor's order sheet, medication record, admission record, and discharge record. The collected data include sex, age, hospitalization date, discharge date, NIHSS score and modified Rankin scale (mRS) at admission and at discharge, stroke lesion location (anterior circulation, posterior circulation, and multiple territories), Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification at discharge, date of detected symptom, neurological symptoms (alertness, aphasia, neglect, limb weakness, dysarthria, facial palsy, sensory, visual disturbance, ataxia), NIHSS scores before and after the time of detection, situation of detection (admission to the ASU, scheduled neurocheck, additional neurocheck, and patient's complaint), shift (day; 7 a.m.-3 pm, evening; 3 p.m.–11 p.m., night; 11 p.m.-7 am), additional clinical management (observation, increasing intravenous fluids, neuro-intervention, taking images), and MR/CT results. Nurses' working years in neurology units were obtained by checking both nursing records and data from the nursing unit regarding the year of appointment to the neurology department.

Using G-power analysis 3.1.9, the sample size was calculated with odds ratio = 1.3, α probability = 0.05, and power = 0.8 for determining the predictive rate of deterioration and the primary outcome variable. As a result, the minimum sample size needed was 568. In this study, 651 cases of neurological symptoms were found in a total of 549 patients, which were finally analyzed.

2.2. Measurements

Neurological symptom. Newly developed or aggravating neurological symptoms were divided into five categories classified in NIHSS scoring system as follows: alertness, cortical sign (visual field defect, aphasia, neglect) [16], motor (limb weakness, dysarthria, facial palsy) [17], sensory, and posterior circulation sign (gaze limitation, ataxia) [18]. We also examined cases that showed symptoms in two or more categories.

Experienced nurse. We divided the nurses according to their level of experience at neurology units by referring to a previous study [19] as follows: novice (1–3 years) and experienced (over 4 years); the contents of nursing work were not different according to the level of experience, and all nurses undertook the same type of nursing work.

Scheduled neurocheck. Neurocheck refers to neurological assessment according to the NIHSS score. The scheduled neurocheck was defined as follows. Patients received a scheduled neurocheck every 4 h except for the following cases in which neurology exams were performed every 2 h: (1) continuous administration of phenylephrine hydrochloride drug, (2) within 24 h of the cerebrovascular procedure, and (3) within 24 h of administration of tissue plasminogen activation.

NIHSS score. NIHSS score was measured from 0 to 42 points in total depending on the severity of symptoms, with higher scores indicating higher neurological severity [20]. NIHSS scores were measured by trained stroke nurses. It categorized as mild (0–6), moderate (7–15), or severe (over 16) as a previous literature [21,22].

mRS. mRS represents the degree of disability after stroke. mRS score of 0–2 indicates the degree of disability that does not require assistance in daily life, a score of 3–5 indicates the need for assistance in daily living, and a score of 6 indicates death [23].

TOAST classification. TOAST classification is categorized according to the stroke etiology as follows [24]: large artery atherosclerosis (LAA), small vessel occlusion (SVO), cardio embolism (CE), other determined (OD), and undetermined (UD).

2.3. Outcome variables

  • 1)

    Stroke lesion progression. The presence of stroke lesion progression indicates that stroke lesion extension or new stroke lesion was found in follow-up MR or CT. The results were judged by experienced neuro-radiologists.

  • 2)

    Early neurological deterioration (END). As defined by the guidelines of the Korea Stroke Registry [25], END was defined as an increase in the total NIHSS score of 2 points or more, an increase in the limb weakness score of 1 point or more, or a decrease in the alertness score of 1 point or more. These criteria represent a standard that is representative of stroke treatment guidelines in South Korea and generally in line with international standards worldwide in stroke care [[26], [27], [28]]. Studies on END have primarily focused on the anterior circulation, while it is widely acknowledged that the NIHSS score has limitations in evaluating the neurological severity of the posterior circulation. Nevertheless, there remains a lack of viable alternatives for its assessment, and presently, it is also utilized in defining END within the posterior circulation [[29], [30], [31]]. Hence, in this study, we aim to define END based on the NIHSS score for both anterior and posterior circulation, conducting research on END in both circulations. However, due to possible collinearity between lesion location and TOAST classification, lesion location was excluded from the multivariable analysis and presented only in the supplementary materials. The END was assessed continuously (additional neurocheck and at patient's complaint) and at specific time points (at admission to the ASU and scheduled neurocheck) in this study.

  • 3)

    Additional clinical management. We examined increases in intravenous fluids, image taking (CT or MR), and neuro-intervention (increasing intravenous fluids or image taking). In our study, neuro-intervention included stent insertion, angioplasty, and thrombectomy in the brain.

2.4. Data analysis

The data was analyzed using the SPSS/WIN 20.0 program, with statistical significance determined by two-sided tests at a p-value of < 0.05 for overall analyses in our study. Descriptive statistics, including mean, standard deviation, and frequency and percentage, were used for descriptive data: demographic characteristics (age, sex), and factors related to early symptom detection. The Chi-squared test was first performed to examine the association between each risk factor (categorical) and our three primary outcomes as categorical variables (presence of stroke lesion progression, END, and additional clinical management) as univariate analyses. Then, to examine the strengths of the effect of factors related to early symptom detection on the three main outcome variables, we conducted multivariable logistic regression for each primary outcome. For the multivariate logistic regression, we only included variables potentially showing significant associations with outcome variables in the univariate analysis. Specifically, when we chose independent variables for the multivariate logistic regression, we used a p < 0.10 as a cutoff point to ensure that potentially important predictors are not omitted from the multivariate analysis.

3. Results

3.1. General characteristics

During the study period, 549 patients showed a total of 651 newly developed or aggravating neurological symptoms that were detected by nurses (Table 1). The average age of the patients was 68.9 ± 12.6 years, and males accounted for 60.1 %. The median (interquartile range) of onset to door time was 15.2 h (0.3–358.8) from the 489 (89.1 %) clear-onset-patients. The median (interquartile range) NIHSS score was 1 (0–7) at admission and 5 (2–8) at discharge. The mRS score was 3 (1–4) at admission and 3 (2–4) at discharge. Among the TOAST classifications, LAA (n = 157, 28.6 %), SVO (n = 146, 26.6 %), and CE (n = 98, 17.9 %) were found, and the newly developed or aggravated symptoms were detected at a mean of 2.7 ± 2.8 days from admission to the ASU. A total of 30 nurses with an average experience in neurology units of 4.3 ± 3.2 years.

Table 1.

General characteristics of the study patients.

Characteristics N = 549
Age (years) 68.9 ± 12.6
Male sex 330 (60.1)
Onset to door time (hours) in clear onset patients 15.2 (0.3–358.8), n = 489 (89.1)
Comorbidities Hypertension 362 (65.9)
Diabetes mellitus 211 (38.4)
Hyperlipidemia 229 (41.7)
Herat disease 192 (34.5)
Previous stroke 147 (26.8)
Current smoker 203 (37.0)
NIHSS score at admission 1 (0–7)
Stroke lesion location Anterior circulation 360 (65.6)
Posterior circulation 162 (29.5)
Multiple lesions 21 (3.8)
TOAST classification LAA 157 (28.6)
SVO 146 (26.6)
CE 98 (17.9)
UD 93 (16.9)
Other 55 (10.0)
NIHSS score on discharge 5 (2–8)
mRS on discharge 3 (2–4)
Detection of symptoms from admission to the ASU, days 2.7 ± 2.8

Data are mean ± standard deviation, median (interquartile range), or N (%).

CE; cardio embolism, LAA; large artery atherosclerosis, mRS; Modified Rankin Scale, NIHSS; National Institutes of Health Stroke Scale, SD; standard deviation, SVO; small vessel occlusion, TOAST; Trial of ORG 10172 in Acute Stroke Treatment, UD; undetermined.

3.2. Symptoms detected by nurses and their related factors

Among the total of 651 symptoms that were detected by nurses, motor-related symptoms were the most common (n = 320, 49.2 %), followed by posterior circulation sign (n = 100, 15.4 %); also, simultaneous symptoms across two or more categories were found in 95 cases (14.6 %; Table 2).

Table 2.

Symptoms detected by nurses and the related factors.

Factors symptoms
Alertness Motor Cortex sign Posterior circulation sign Sensory ≥2 categories Total
Neurological working years 1–3 years 25 (65.8)a 181 (56.6)a 36 (53.7)a 60 (60.0)a 22 (71.0)a 48 (50.5)a 372 (57.1)b
Over 4 years 13 (34.2)a 139 (43.4)a 31 (46.3)a 40 (40.0)a 9 (29.0)a 47 (49.5)a 279 (42.9)b
Shift Day 29 (76.3)a 156 (48.8)a 27 (40.3)a 58 (58.0)a 20 (64.5)a 42 (44.2)a 332 (51.0)b
Evening 5 (13.2)a 83 (25.9)a 15 (22.4)a 24 (24.0)a 6 (19.4)a 30 (31.6)a 163 (25.0)b
Night 4 (10.5)a 81 (25.3)a 25 (37.3)a 18 (18.0)a 5 (16.1)a 23 (24.2)a 156 (24.0)b
Situation Admission to the acute stroke unit 2 (5.3)a 40 (12.5)a 7 (10.4)a 25 (25.0)a 5 (16.1)a 29 (30.5)a 108 (16.6)b
Scheduled neurocheck 24 (63.2)a 245 (76.6)a 53 (79.1)a 66 (66 0)a 20 (64.5)a 56 (58.9)a 464 (71.3)b
Nurse's additional neurocheck 5 (13.2)a 14 (4.4)a 6 (9.0)a 8 (8.0)a 2 (6.5)a 9 (9.5)a 44 (6.8)b
Patient's own complaints 7 (18.4)a 21 (6.6)a 1 (1.5)a 1 (1.0)a 4 (12.9)a 1 (1.1)a 35 (5.4)b
TOAST LAA 9 (23.7)a 101 (31.6)a 21 (31.3)a 28 (28.0)a 7 (22.6)a 35 (36.8)a 201 (30.9)b
SVO 4 (10.5)a 106 (33.1)a 5 (7.5)a 30 (30.0)a 11 (35.5)a 19 (20.0)a 175 (26.9)b
CE 10 (26.3)a 35 (10.9)a 22 (32.8)a 22 (22.0)a 5 (16.1)a 16 (16.8)a 110 (16.9)b
UD 11 (28.9)a 52 (16.3)a 9 (13.4)a 14 (14.0)a 5 (16.1)a 13 (13.7)a 104 (16.0)b
OD 4 (10.5)a 26 (8.1)a 10 (14.9)a 6 (6.0)a 3 (9.7)a 12 (12.6)a 61 (9.4)b
Additional clinical management Observation 13 (34.2)a 146 (45.6)a 41 (61.2)a 65 (65.0)a 18 (58.1)a 43 (45.3)a 326 (50 1)b
Increasing intravenous fluids 2 (5.3)a 130 (40.6)a 12 (17 0.9)a 17 (17.0)a 13 (41 9)a 27 (28.4)a 201 (30.9)b
Taking image only 13 (34.2)a 30 (9.4)a 7 (10.4)a 10 (10.0)a 0 (0.0)a 14 (14.7)a 74 (11.4)b
Taking image & increasing intravenous fluids 4 (10.5)a 5 (1.6)a 3 (4.5)a 4 4.0)a 0 (0.0)a 6 (6.3)a 22 (3.4a)b
Neuro-intervention 6 (15.8)a 9 (2.8)a 4 (6.0)a 4 (4.0)a 0 (0.0)a 5 (5.3)a 28 (4.3)b
Total 38 (5.8)c 320 (49.2)c 67 (10.3)c 100 (15.4)c 31 (4.8)c 95 (14.6)c 651 (100.0)

Data are n (%), CE; cardio embolism, LAA; large artery atherosclerosis, OD; other determined, SVO; small vessel occlusion, TOAST; Trial of ORG 10172 in Acute Stroke Treatment, UD; undetermined.

a

percentages according to symptoms.

b

percentages according to factors.

c

percentages according to total cases.

Of the 651 symptoms, 372 (57.1 %) were detected by nurses with 1–3 years of experience in neurology units, and the rest were detected by nurses with over 4 years of experience; particularly, nurses with 1–3 years of experience detected the majority of alertness (n = 25/38, 65.8 %) and sensory symptoms (n = 22/31, 71.0 %). In terms of the situation variables, the majority of symptoms (n = 464, 71.3 %) were detected during the nurses’ scheduled neurocheck.

In terms of TOAST classification, symptoms were most commonly found in cases of LAA (n = 201, 30.9 %) and SVO (n = 175, 26.9 %). Simultaneous symptoms of two or more categories were most commonly found in LAA (n = 35/95, 36.8 %). In SVO cases, motor symptom (n = 106/320, 33.1 %) was the most common symptom. Of the reported symptoms, 49.9 % (n = 525/651) received additional clinical management, among which intravenous fluids increase (n = 201/651, 30.9 %) was the most common. Image taking was the most common clinical management in cases that showed change in alertness (n = 23/38, 60.5 %) and simultaneous symptoms in two or more categories (n = 25/95, 27.2 %).

3.3. Factors related to the presence of stroke lesion progression

A total of 132 patients underwent image taking according to symptom detection, of whom 83 (63.6 %) were found to have stroke lesion progression (Table 3). In the multivariate analysis, stroke lesion progression was more likely to be found in the group of NIHSS score of 7–15 at admission (OR = 11.68, 95 % CI = 1.46–93.69, p = 0.021) compared with the group of NIHSS score of over 16. Also, nurses with over 4 years of experience detected more stroke lesion progression than by those with 1–3 years of experience (OR = 2.49, 95 % CI = 1.09–5.66, p = 0.030). In terms of TOAST classification, stroke lesion progression was the most likely to be found in cases classified as LAA (OR = 36.62, 95 % CI = 4.86–275.99, p ≤ 0.001) compared with SVO.

Table 3.

Factors related to stroke lesion progression.

Taking image Stroke lesion progression Stroke lesion progression rate (%) pa Univariate analysis
Multivariate analysis
OR 95 % CI p OR 95 % CI p
Age (year) ≥80 22 11 50.0 0.491 Reference
20≤ <40 4 3 75 1.40 0.05-0.43.17 0.849
40≤ <60 23 16 69.6 1.88 0.26–13.57 0.532
60≤ <80 83 54 65.1 1.08 0.23–5.09 0.923
Gender Female 48 30 62.5 Reference
Male 84 54 64.3 0.837 0.66 0.20–2.17 0.490
Onset to door time <72 h 9 4 44.4 Reference
72 h≤ <7 days 75 45 60.0 1.36 0.15–12.14 0.781
≥7 days 39 29 74.4 0.151 2.40 0.26–22.00 0.440
Comorbidities Hypertension 96 59 61.5 0.396 0.77 0.21–2.79 0.687
Diabetes Mellitus 48 34 70.8 0.194 2.56 0.78–8.39 0.120
Hyperlipidemia 53 37 69.8 0.227 2.29 0.70–7.50 0.172
Heart disease 39 24 61.5 0.746 1.35 0.36–5.09 0.659
Previous stroke 32 20 62.5 0.878 0.79 0.24–2.64 0.704
Current smoker 40 25 65.2 0.858 1.50 0.43–5.28 0.527
NIHSS score at admission ≥16 6 2 33.3 0.210 Reference Reference
0–6 98 62 74.2 96.30 2.63–3530.21 0.013 0.73 0.26–2.08 0.559
7–15 28 20 71.4 62.57 1.67–2348.40 0.025 11.65 1.46–93.69 0.021
Detected symptoms Alertness 24 13 54.2 Reference
Motor 46 27 58.7 0.98 0.22–4.48 0.983
Cortex sign 17 13 76.5 0.18 0-02-1.59 0.122
Posterior circulation sign 18 12 66.7 0.58 0.08–4.08 0.584
Two or more categories 27 19 70.4 0.521 0.47 0.08–2.88 0.413
Neurological working years 1–3 years 72 41 56.9 Reference Reference
Over 4 years 60 43 71.7 0.080 2.87 0.98–8.40 0.055 2.49 1.09–5.66 0.030
Shift Night 21 12 57.1 Reference
Day 82 54 65.9 2.88 0.59–14.08 0.192
Evening 29 18 62.1 0.745 4.39 0.73–26.27 0.105
Situation Patient's own complaints 12 5 41.7 Reference Reference
Scheduled neurocheck 88 57 64.8 6.87 1.02–46.25 0.048 2.98 0.49–18.28 0.238
Admission to the acute stroke unit 16 10 62.5 1.75 0.22–13.93 0.598 1.43 0.38–5.33 0.596
Nurse's additional neurocheck 16 12 75.0 0.327 24.21 1.75–335.88 0.018 2.67 0.49–14.48 0.256
TOAST SVO 17 6 35.3 Reference Reference
LAA 39 24 61.5 6.16 1.23–30.93 0.027 36.62 4.86–275.99 <001
CE 30 22 73.3 19.56 2.99–128.01 0.002 15.10 2.33–97.78 0.004
UD 24 12 50.0 2.85 0.49–16.58 0.244 5.75 0.88–37.42 0.067
OD 22 20 90.9 0.003 93.36 7.95–1096.24 <0.001 21.37 3.11–147.01 0.002
Total 132 84 63.6 <0.001

CI; confidential interval, CE; cardio embolism, LAA; large artery atherosclerosis, OD; other determined, NIHSS; National institute of health stroke scale, OR; odds ratio, SVO; small vessel occlusion, TOAST; Trial of ORG 10172 in Acute Stroke Treatment, UD; undetermined.

a

was based on chi-square test.

3.4. Factors related to the presence of early neurological deterioration

END was reported in 460 cases (70.7 %; Table 4). Scheduled neurocheck had the highest association with the detection of END (OR = 2.65, 95 % CI = 1.04–6.72, p = 0.040) compared with patient's own complaints in the situation factors. Among the TOAST classifications, END was more likely to be found in LAA (OR = 2.19, 95 % CI = 1.06–4.49, p = 0.033) compared with SVO. As the definition of END, incorporating NIHSS, is primarily employed in the anterior circulation, we conducted a separate analysis of END in the anterior circulation and presented it in the supplementary material. The findings indicated a similar significance of scheduled neurochecks (supplementary materials, Table 1).

Table 4.

Factors related to early neurological deterioration.

Detected case END END rate (%) pa Univariate analysis
Multivariate analysis
OR 95 % CI p OR 95 % CI p
Age (year) 20≤ <40 13 10 76.9 Reference
40≤ <60 122 79 64.8 1.29 0.28–5.85 0.746
60≤ <80 405 285 70.4 1.59 0.36–7.05 0.541
≥80 111 86 77.5 0.187 1.94 0.41–9.17 0.403
Gender Female 256 184 71.9 Reference
Male 395 276 69.9 0.584 1.05 0.71–1.55 0.817
Onset to door time <72 h 52 40 76.9 Reference
72 h≤ <7 days 328 227 69.2 0.70 0.33–1.48 0.354
≥7 days 212 152 71.7 0.490 0.82 0.38–1.77 0.609
Comorbidities Hypertension 442 317 71.7 0.388 1.04 0.68–1.58 0.857
Diabetes Mellitus 250 177 70.8 0.951 1.16 0.77–1.73 0.482
Hyperlipidemia 278 192 69.1 0.440 0.85 0.58–1.25 0.404
Heart disease 132 93 70.5 0.954 0.96 0.58–1.57 0.867
Previous stroke 164 16 70.7 0.982 1.05 0.68–1.63 0.834
Current smoker 242 168 69.4 0.593 1.00 0.68–1.47 0.995
NIHSS score at admission 0–6 505 340 67.3 Reference Reference
7–15 122 99 81.1 1.88 1.11–3.19 0.019 2.79 0.80–9.77 0.109
≥16 24 21 87.5 0.006 4.58 1.00–20.97 0.050 1.51 0.41–5.62 0.540
Neurological working years 1–3 years 372 258 69.4 Reference
Over 4 years 279 202 72.4 0.434 1.17 0.80–1.72 0.426
Shift Day 332 233 70.2 Reference
Evening 163 116 71.2 0.0.92 0.58–1.47 0.726
Night 156 111 71.2 0.963 0.92 0.58–1.46 0.731
Situation Patient's own complaints 35 14 40.0 Reference Reference
Scheduled neurocheck 464 341 73.5 3.45 1.57–7.60 0.002 2.65 1.04–6.72 0.040
Admission to the acute stroke unit 108 76 70.4 3.15 1.30–7.64 0.011 0.66 0.341.29 0.224
Nurse's additional neurocheck 44 29 65.9 <0.001 1.97 0.72–5.41 0.188 0.76 0.35–1.63 0.479
TOAST SVO 175 108 61.7 Reference Reference
LAA 201 147 73.1 1.42 0.88–2.30 0.153 2.19 1.06–4.49 0.033
CE 110 82 74.5 1.26 0.70–2.25 0.446 1.41 0.692.90 0.347
UD 104 74 71.2 1.40 0.78–2.49 0.258 1.48 0.68–3.24 0.327
OD 61 49 80.3 0.028 2.30 1.04–5.09 0.039 1.53 0.70–3.33 0.284
Total 651 460 70.7 <0.001

CI; confidential interval, CE; cardio embolism, END; early neurological deterioration, LAA; large artery atherosclerosis, OD; other determined, NIHSS; National institute of health stroke scale, OR; odds ratio, SVO; small vessel occlusion, TOAST; Trial of ORG 10172 in Acute Stroke Treatment, UD; undetermined.

a

was based on chi-square test.

3.5. Factors related to the presence of additional clinical management

Of the symptoms detected by nurses, 49.9 % (n = 325) were subject to receive an additional clinical management (Table 5). Additional clinical managements did 1.53 times more with patients with heart disease (OR = 1.53, 95 % CI = 1.02–2.31, p = 0.041). In the group of NIHSS score 0–6 was taken more additional clinical managements (OR = 3.25, 95 % CI = 1.13–9.37, p = 0.029) compared with the group of NIHSS score over 16. Alertness (OR = 2.89, 95 % CI = 1.58–5.26, p = 0.001) had the highest rates of additional clinical management (p = 001). Among the situational factors, scheduled neurocheck had the highest rate of additional clinical management (OR = 4.77, 95 % CI = 2.18–10.39, p < 0.001) compared with the detection at the admission to stroke unit.

Table 5.

Factors related to additional clinical management.

Detected case Additional management Rate of additional clinical management (%) pa Univariate analysis
Multivariate analysis
OR 95 % CI p OR 95 % CI p
Age (year) 20≤ <40 13 6 46.2 Reference
40≤ <60 122 71 58.2 2.88 0.70–11.89 0.143
60≤ <80 405 194 47.9 1.82 0.46–7.28 0.395
≥80 111 54 48.6 0.246 2.20 0.53–9.21 0.281
Gender Female 256 128 50.0 Reference
Male 395 197 49.9 0.975 1.10 0.76–1.59 0.631
Onset to door time <72 h 52 31 59.6 Reference
72 h≤ <7 days 328 156 47.6 0.73 0.37–1.42 0.352
≥7 days 212 106 50.0 0.267 0.88 0.44–1.79 0.725
Comorbidities Hypertension 229 213 48.2 0.161 1.38 0.93–2.07 0.114
Diabetes Mellitus 250 124 49.6 0.896 0.95 0.65–1.39 0.792
Hyperlipidemia 278 131 47.1 0.217 0.78 0.54–1.12 0.172
Heart disease 132 75 56.8 0.076 1.61 0.10–2.60 0.051 1.53 1.02–2.31 0.041
Previous stroke 164 87 53.0 0.355 1.14 0.76–1.74 0.513
Current smoker 242 122 46.3 0.153 0.81 0.56–1.17 0.259
NIHSS score at admission 0–6 505 259 51.3 4.58 1.40–15.05 0.012 3.25 1.13–9.37 0.029
7–15 122 60 49.2 3.26 0.96–11.02 0.058 0.78 0.51–1.18 0.240
≥16 24 6 25.0 0.085 Reference Reference
Detected symptoms Posterior circulation sign 100 35 35.0 Reference Reference
Alertness 38 25 65.8 4.83 1.97–11.86 0.001 2.89 1.58–5.26 0.001
Motor 320 174 54.4 2.48 1.47–4.18 0.001 0.68 0.29–1.57 0.365
Cortex sign 67 26 38.8 1.67 0.80–3.50 0.172 1.12 0.69–1.82 0.648
Sensory 31 13 41.9 1.01 0.40–2.52 0.983 1.69 0.85–3.35 0.136
Two or more categories 95 52 54.7 <0.001 2.45 1.28–4.69 0.007 2.12 0.90–4.99 0.084
Neurological working years 1–3 years 372 177 47.6 Reference
Over 4 years 279 148 53.0 0.179 1.30 0.90–1.87 0.165
Shift Evening 163 75 46.0 Reference
Day 332 174 52.4 1.14 0.73–1.78 0.553
Night 156 76 48.7 0.385 0.97 0.59–1.62 0.915
Situation Admission to the acute stroke unit 108 32 29.6 Reference Reference
Scheduled neurocheck 464 243 52.4 2.58 1.53–4.37 <0.001 4.76 2.18–10.39 <0.001
Patient's own complaints 44 29 65.9 3.80 1.46–9.87 0.006 1.86 0.94–3.66 0.073
Nurse's additional neurocheck 35 21 60.0 <0.001 5.15 2.22–11.95 <0.001 1.75 0.67–4.57 0.460
TOAST CE 110 43 39.1 Reference
LAA 201 102 50.7 1.54 0.89–2.67 0.122
SVO 175 94 53.7 1.70 0.95–3.06 0.075
UD 104 48 46.2 1.24 0.66–2.31 0.502
OD 61 38 62.3 0.032 2.03 0.94–4.37 0.071
Total 651 325 49.9 <0.001

CI; confidential interval, CE; cardio embolism, END; early neurological deterioration, LAA; large artery atherosclerosis, OD; other determined, NIHSS; National institute of health stroke scale, OR; odds ratio, SVO; small vessel occlusion, TOAST; Trial of ORG 10172 in Acute Stroke Treatment, UD; undetermined.

a

was based on chi-square test.

4. Discussion

In this study, we analyzed the factors related to the nurses' detection of newly developed or aggravating symptoms in the ASU, presence of stroke lesion progression, END, and additional clinical management. Of the 549 patients who had neurological changes, 651 symptoms were found on an average of 2.70 ± 2.78 days, which is in line with previous studies [[3], [4], [5], [6],26,32,33] those are support the notion that neurological symptoms worsen significantly within the first 72 h, emphasizing the importance of closely monitoring changes in patient condition as highlighted in prior studies. Collectively, our study suggests the importance of appropriate neurological detections in the early stages of symptom onset.

The most commonly detected symptom was motor progression. The possibility of motor change is the same as those shown in previous studies that analyzed the records of nurses' change findings in the ASU [11,34,35]; this may be because motor function evaluation is the most widely used factor in the assessment of acute stroke patients, as it is a well-known symptom of cerebral infarction. Also, a considerable portion of patients reported neurological symptom changes in two or more symptom categories, indicating that stroke patients might experience multiple co-occurring symptom changes.

We found that changes in alertness were frequently detected during the day shift (76.4 %), and that such cases most commonly underwent diagnostic imaging (60.5 %), followed by neuro-interventions (15.8 %). Alertness is the most powerful factors influenced on the presence of additional clinical management up to 2.89 times more in detected symptoms. These results indicate that changes in alertness may serve as an important indicator of neurological deterioration by nurses, specifically during the day shift, who should be aware of this symptom and provide early interventions [32].

Nurses most frequently detected overall symptom changes during the day shifts. In a previous meta-analysis, 49 % of stroke onset was reported in the morning hours due to the interplay of the circadian rhythm with the onset of neurological symptoms [36]. The higher number of professional medical staff in the ASU during daylight hours might also contribute to this result. For example, stroke clinical nurse specialists and the majority of neurologists work during day shifts, and the increase in the number of nursing staff has a positive effect on the prevention of exacerbation of patients [37]. Also, one study showed that an expanded system with more than one stroke physician on standby in the ASU can help improving the prognosis of stroke patients [38]. It is also important to keep the appropriate level of nursing ratio (patient: nurse = 1.25:1 or less) as suggested by the Health Insurance Review and Assessment Service of South Korea [39]. The average number of beds per nurse in this study was 1.125:1, which might have influenced the rate of symptom detection.

Symptom changes in two or more categories (26.9 %) and the posterior circulation signs (23.1 %) were most commonly found when admission to the ASU. Therefore, it is important to shorten the waiting time of stroke patients in the emergency department to prevent the worsening of the prognosis [35,40]. Considering that stroke patients tend to show deterioration in symptoms during transfers [41], optimal communication between medical staff in the emergency room and stroke units about the neurological status of stroke patients is needed.

There were differences between the examination by residents in the emergency room and stroke unit nurses, especially in terms of the posterior circulation sign in our study. This may be due to difficulties in directly checking the walking status in the emergency room and the accurate identification of symptoms due to changes in the patient's acute condition. Also, there may have been some omissions in the neurological examination when the patients are being quickly examined in the emergency department.

There were totally 1603 patients in acute stroke unit of our hospital and 282 patients were defined as END (17.6 %) in the study period. In previous study about acute stroke patient within 72 h from symptom onset, approximately 14.1 % patients were occurred of END which is similar with our results [26]. Of the situations, scheduled neurochecks was not only tended to have a significant impact on END, but also was the highest rate of presence of additional clinical managements. In a previous study, ∼45 % of neurological deteriorations in stroke patients were detected during scheduled neurochecks [41]. The rate of early detection is affected by the basic rules of rounds in the ASU, although the definition of scheduled neurocheck may be different in each clinical situation. Periodic rounding therefore seems to be important in this area.

Additional clinical management was performed in 49.9 % of cases with symptom changes that were detected by nurses, which in turn contributed to the prevention of deterioration. In the cases that underwent diagnostic imaging, changes in alertness or in two or more categories were the most frequent cases. Additional clinical management was 5.15 times more likely to be provided to cases that were detected during additional neurochecks compared with those that were detected at admission to the ASU in the univariate analysis. This suggests that nurses detecting changes during additional neurochecks was likely to lead to the attending doctors being more mindful of the notification. In a prior study, nurses discovered about 26 % of END cases outside of scheduled neurochecks [41]. Nurses’ experience would be important for judging the situation during not only routine examinations but also in additional neurochecks.

Stroke lesion progression, which can be regarded as a more objective indicator of detecting stroke deterioration than the presence of END or additional clinical management, was present in 63.6 % of cases with symptom changes that were detected by nurses. In another study, the detection rate of stroke lesion progression according to the neurological changes by nurses was 47.0 % after one year of NIHSS application in the ASU [11]. Our study was conducted 8.5 years after the application of the NIHSS to nurses.

The group of NIHSS score of 7–15 which means moderate stroke severity and LAA stroke patients were highly influenced on detect the stroke lesion progression in our results. Among the TOAST classification, LAA was also the highest relating factor in the presence of END. That is similar to previous studies [42] which represented that stroke deterioration was found mostly in the group of LAA than other stroke subtypes.

Stroke lesion deterioration was 2.41 times more likely to be detected by nurses with 4 or more years of experience than those with 1–3 years of experience. It is important for nurses to acquire plenty of experience with stroke patients and receive systematic ASU education. The ASU certification criteria [43] presented by the Korean Stroke Society include a certain level of stroke education for nurses. In Korea, a self-e-learning course completes the NIHSS score through video, but this is optional [44] and not mandatory in hospital settings. Also, there are no essential guidelines to evaluate the content or results of education for stroke nurses. The content and effectiveness of education should also be checked rather than just measuring the length of education.

Nurses' detection of changes in stroke symptoms might be positively affected by comprehensive education and management of stroke clinical nurse specialists. There was a stroke clinical nurse specialist in this research, and the theory and practical education on stroke were provided to novice nurses one-on-one or in groups until they started working in the ASU. In addition, the clinical nurse specialist shared knowledge on matters that the nurses should intensively check with regard to the patient's status. While some hospitals have stroke clinical nurse specialists or coordinator nurses, there are no qualification requirements for them. Therefore, it is necessary to prepare structural guidelines for the Korean Stroke Society and develop a comprehensive and systematic program.

5. Limitations

Our study has the following limitations. First, the results were gathered from a single ASU in a tertiary hospital in Korea. Also, due to the retrospective study design, we could not check the reasons for nurses’ additional neurochecks or examine the reasons for stroke deterioration. Lastly, in this study, the clinical nurse specialist was managing stroke patients and nurses in this hospital, but it was not possible to measure the effects of this. Continued researches are necessary to fully understand the impact of clinical nurse specialists and to optimize their role in clinical setting.

6. Conclusions

The most detected symptom was motor changes, and deterioration of symptoms were the most likely to be found during day shifts, scheduled neurochecks, and in LAA cases. We studied about related factor to 3 main outcomes: the presence of stroke lesion progression, END, and additional clinical management. Stroke lesion progression were detected highly in the group of NIHSS score 7–15, experienced nurses over 4 years of neurology unit, and LAA stroke subtype patients. In terms of detecting END, scheduled neurochecks and the group of LAA showed the highest detection rate. In the case of the presence of additional clinical management, factors such as heart disease, NIHSS score of 0–6, changes of alertness, and scheduled neurochecks showed a high level of influences.

Our results can serve as a basis for improving the factors related to the nursing quality of acute cerebral infarction patients. It is needed to apply systematic guidelines for the education and qualification of stroke nurses, which would be useful for an expanded study about the clinical changes of stroke patients other than their neurological changes that can be detected by nurses.

Funding statement

This research was supported by the Brain Convergence Research Program of the National Research Foundation funded by the Korean government (No. 2020M3E5D2A01084576) and the National Research Foundation of Korea grant funded by the Korean government (MSIT) (No. 2020R1A2C2100077).

Ethics and consent

• This study was reviewed and approved by the Institutional Review Board of Asan Medical Center on April 15, 2021, with the approval number: [2021-0571].

• Informed consent was not required for this study because it was conducted retrospectively using medical records of patients who underwent routine stroke treatments, so that this study was determined by the IRB to pose no risk to the subjects involved.

Data availability

All data used in the generation of the results presented in this manuscript will be made available upon reasonable request from the corresponding author.

CRediT authorship contribution statement

Jung-Hee Han: Writing – review & editing, Writing – original draft, Visualization, Validation, Project administration, Methodology, Formal analysis, Data curation, Conceptualization. Claire Han: Writing – review & editing, Validation, Formal analysis. Sunmae Park: Resources, Project administration, Data curation. Young-Joo Kim: Resources, Project administration, Data curation. Bum Joon Kim: Writing – review & editing, Visualization, Validation, Supervision, Resources, Funding acquisition, Formal analysis.

Declaration of competing interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Bum Joon Kim reports financial support and article publishing charges were provided by the Brain Convergence Research Program of the National Research Foundation funded by the Korean government. Bum Joon Kim reports financial support and article publishing charges were provided by the National Research Foundation of Korea grant funded by the Korean government.

Acknowledgments

There are no acknowledgements.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.heliyon.2024.e32175.

Contributor Information

Jung-Hee Han, Email: hee972@naver.com.

Claire Han, Email: Han.1985@osu.edu.

Sunmae Park, Email: psm-1004@daum.net.

Young-Joo Kim, Email: kyjkbs@amc.seoul.kr.

Bum Joon Kim, Email: medicj80@hanmail.net, bj.kim@amc.seoul.kr.

Abbreviations

ASU

acute stroke unit

CE

cardio embolism

END

Early neurological deterioration

LAA

large artery atherosclerosis

mRS

modified Rankin Scale

NIHSS

National Institutes of Health Stroke Scale

OD

other determined

SVO

small vessel occlusion

TOAST

Trial of ORG 10172 in Acute Stroke Treatment

UD

undetermined

Appendix A. Supplementary data

The following is the Supplementary data to this article.

Multimedia component 1
mmc1.docx (22.9KB, docx)

References

  • 1.Clery A., et al. Trends in prevalence of acute stroke impairments: a population-based cohort study using the South London Stroke Register. PLoS Med. 2020;17(10) doi: 10.1371/journal.pmed.1003366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.GBD 2017 DALYs and Hale Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi: 10.1016/S0140-6736(18)32335-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Birschel P., Ellul J., Barer D. Progressing stroke: towards an internationally agreed definition. Cerebrovasc. Dis. 2004;17(2–3):242–252. doi: 10.1159/000076161. [DOI] [PubMed] [Google Scholar]
  • 4.Helleberg B.H., Ellekjaer H., Indredavik B. Outcomes after early neurological deterioration and transitory deterioration in acute ischemic stroke patients. Cerebrovasc. Dis. 2016;42(5–6):378–386. doi: 10.1159/000447130. [DOI] [PubMed] [Google Scholar]
  • 5.Thanvi B., Treadwell S., Robinson T. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad. Med. 2008;84(994):412–417. doi: 10.1136/pgmj.2007.066118. [DOI] [PubMed] [Google Scholar]
  • 6.Weimar C., et al. Neurologic worsening during the acute phase of ischemic stroke. Arch. Neurol. 2005;62(3):393–397. doi: 10.1001/archneur.62.3.393. [DOI] [PubMed] [Google Scholar]
  • 7.Kwan J., Hand P. Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM. 2006;99(9):625–633. doi: 10.1093/qjmed/hcl082. [DOI] [PubMed] [Google Scholar]
  • 8.Liu P., et al. Association between neurological deterioration and outcomes in patients with stroke. Ann. Transl. Med. 2020;8(1):4. doi: 10.21037/atm.2019.12.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kim J.Y., et al. Executive summary of stroke statistics in Korea 2018: a report from the epidemiology research council of the Korean stroke society. J Stroke. 2019;21(1):42–59. doi: 10.5853/jos.2018.03125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Park K.H., et al. Nursing quality improvement for acute stroke patients through the use of NIHSS. J Kor Soc Qual Assur Health Care. 2009;15(2):73–81. [Google Scholar]
  • 11.Han J.H., et al. Effect of systematic educational program for the application of National Institutes of Health Stroke Scale (NIHSS) as a neurologic assessment tool in stroke patients. Journal of Korean Clinical Nursing Research. 2013;19(1):57–68. [Google Scholar]
  • 12.Chung W., Sohn M. The impact of nurse staffing on in-hospital mortality of stroke patients in Korea. J. Cardiovasc. Nurs. 2018;33(1):47–54. doi: 10.1097/JCN.0000000000000415. [DOI] [PubMed] [Google Scholar]
  • 13.Clayton B. Clustered stroke patients on a general medical unit: what nursing skills and knowledge contribute to optimal patient outcomes? Can. J. Neurosci. Nurs. 2014;36(3):32–40. [PubMed] [Google Scholar]
  • 14.Jackson N., et al. Reflections on 50 years of neuroscience nursing: the growth of stroke nursing. J. Neurosci. Nurs. 2018;50(4):188–192. doi: 10.1097/JNN.0000000000000375. [DOI] [PubMed] [Google Scholar]
  • 15.Novak A. The effect of a simulation-based education program on NIHSS accuracy and inter-rater reliability among nursing staff in the neurological/neurosurgical intensive care unit. 2019. https://uknowledge.uky.edu/dnp_etds/271 [cited 2022 Nov 15]; Available from:
  • 16.Teleb M.S., et al. Stroke vision, aphasia, neglect (VAN) assessment-a novel emergent large vessel occlusion screening tool: pilot study and comparison with current clinical severity indices. J Neurointerv Surg. 2017;9(2):122–126. doi: 10.1136/neurintsurg-2015-012131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kelly-Hayes M., et al. The American Heart Association stroke outcome classification. Stroke. 1998;29(6):1274–1280. doi: 10.1161/01.str.29.6.1274. [DOI] [PubMed] [Google Scholar]
  • 18.Alemseged F., et al. Posterior National Institutes of Health Stroke Scale improves prognostic accuracy in posterior circulation stroke. Stroke. 2022;53(4):1247–1255. doi: 10.1161/STROKEAHA.120.034019. [DOI] [PubMed] [Google Scholar]
  • 19.Health Insurance Review and Assessment Service . 2018. Medical Quality Evaluation Guidelines.https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=7070#none [cited 2022 November 15]; Available from: [Google Scholar]
  • 20.van Swieten J.C., et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–607. doi: 10.1161/01.str.19.5.604. [DOI] [PubMed] [Google Scholar]
  • 21.Adams H.P., J, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke. A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) 1999;53(1) doi: 10.1212/wnl.53.1.126. 126-126. [DOI] [PubMed] [Google Scholar]
  • 22.Tseng M.C., Chang K.C. Stroke severity and early recovery after first-ever ischemic stroke: results of a hospital-based study in Taiwan. Health Pol. 2006;79(1):73–78. doi: 10.1016/j.healthpol.2005.12.003. [DOI] [PubMed] [Google Scholar]
  • 23.Bamford J.M., et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989;20(6):828. doi: 10.1161/01.str.20.6.828. [DOI] [PubMed] [Google Scholar]
  • 24.Adams H.P., Jr., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi: 10.1161/01.str.24.1.35. [DOI] [PubMed] [Google Scholar]
  • 25.Korean Stroke Society . 2017. Korean Stroke Registry Guideline.http://www.strokedb.or.kr/popup/170523/KSR_guideline_version1.0_reference.pdf [cited 2022 November 15]; Available from: [Google Scholar]
  • 26.Liu H., et al. Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study. Ther Adv Neurol Disord. 2023;16 doi: 10.1177/17562864221147743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.London K.s.C. National clinical guideline for stroke for the United Kingdom and Ireland. 2023. https://www.strokeguideline.org/app/uploads/2023/04/National-Clinical-Guideline-for-Stroke-2023.pdf [cited 2023 September 26]; Available from:
  • 28.Leicester U.H.o. 2022. Stroke and TIA Management in Adults: Guidelines for the First 72 Hours of Symptom-Onset. secure.library.leicestershospitals.nhs.uk/PAGL/Shared%20Documents/Stroke%20and%20TIA%20UHL%20Guideline.pdf. [Google Scholar]
  • 29.Li H., et al. Risk factors and prognosis of early neurological deterioration in patients with posterior circulation cerebral infarction. Clin. Neurol. Neurosurg. 2023;228 doi: 10.1016/j.clineuro.2023.107673. [DOI] [PubMed] [Google Scholar]
  • 30.Cui Y., Meng W.-H., Chen H.-S. Early neurological deterioration after intravenous thrombolysis of anterior vs posterior circulation stroke: a secondary analysis of INTRECIS. Sci. Rep. 2022;12(1):3163. doi: 10.1038/s41598-022-07095-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Nam K.-W., Kwon H.-M., Lee Y.-S. Different predictive factors for early neurological deterioration based on the location of single subcortical infarction. Stroke. 2021;52(10):3191–3198. doi: 10.1161/STROKEAHA.120.032966. [DOI] [PubMed] [Google Scholar]
  • 32.Chou C., Bourekas E.C., Slivka A. Clinical deterioration and early imaging changes after intravenous tissue plasminogen activator administration in acute ischemic stroke patients. J. Stroke Cerebrovasc. Dis. 2016;25(7):1823–1827. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.016. [DOI] [PubMed] [Google Scholar]
  • 33.Cuadrado-Godia E. Early neurological deterioration, easy methods to detect it. Indian J. Med. Res. 2015;141(3):266–268. doi: 10.4103/0971-5916.156547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kothari R., et al. Patients' awareness of stroke signs, symptoms, and risk factors. Stroke. 1997;28(10):1871–1875. doi: 10.1161/01.str.28.10.1871. [DOI] [PubMed] [Google Scholar]
  • 35.Mosley I., et al. Triage assessments and the activation of rapid care protocols for acute stroke patients. Australas. Emerg. Nurs. J. 2013;16(1):4–9. doi: 10.1016/j.aenj.2012.12.002. [DOI] [PubMed] [Google Scholar]
  • 36.Mackey J., et al. Population-based study of wake-up strokes. Neurology. 2011;76(19):1662–1667. doi: 10.1212/WNL.0b013e318219fb30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kim J.E. Department of Nursing Science Ewha Womans University; 2020. Association between Nurse Staffing Level and Mortality of Stroke Patients in the Intensive Care Units. [Google Scholar]
  • 38.Health Insurance Review And Assessment Service . 2017. Health Insurance Act Reimbursement/non-Reimbursement List Table and Reimbursement Relative Value Score (2017-148)https://www.hira.or.kr/cms/inform/01/1355906_27106.html [cited 2022 November 16]; Available from: [Google Scholar]
  • 39.Health Insurance Review And Assessment Service . 2020. Details on Application Standards and Methods of Medical Care Benefit (2020-186)https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020002000100&brdScnBltNo=4&brdBltNo=8153 [cited 2022 November 15]; Available from: [Google Scholar]
  • 40.Kinsella D., Mosley I., Braitberg G. A Retrospective Study Investigating: factors associated with mode of arrival and emergency department management for patients with acute stroke. Australas Emerg Care. 2018;21(3):99–104. doi: 10.1016/j.auec.2018.07.001. [DOI] [PubMed] [Google Scholar]
  • 41.De Leon Benedetti A.M., et al. How well do neurochecks perform after stroke? Stroke. 2021;52(3):1094–1097. doi: 10.1161/STROKEAHA.120.032303. [DOI] [PubMed] [Google Scholar]
  • 42.Kim J.-T., et al. Frequency, management, and outcomes of early neurologic deterioration due to stroke progression or recurrence. J. Stroke Cerebrovasc. Dis. 2023;32(2) doi: 10.1016/j.jstrokecerebrovasdis.2022.106940. [DOI] [PubMed] [Google Scholar]
  • 43.Korean Stroke Society . 2020. Guidelines of Thrombectomy Capable Stroke Center.https://www.stroke.or.kr/file/stroke_evaluation_criteria_file.pdf [cited 2022 November 15]; Available from: [Google Scholar]
  • 44.Korean Stoke Society. K-NIHSS. 2022. http://www.stroke-edu.or.kr/ [cited 2022 November 15]; Available from: [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (22.9KB, docx)

Data Availability Statement

All data used in the generation of the results presented in this manuscript will be made available upon reasonable request from the corresponding author.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES